Italia markets closed

CV Sciences, Inc. (0HRT.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
0,1700-0,0100 (-5,56%)
Alla chiusura: 03:41PM GMT
Schermo intero
Chiusura precedente0,1800
Aperto0,1771
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,1700 - 0,1771
Intervallo di 52 settimane0,1700 - 0,1771
Volume100.000
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)0,81
Rapporto PE (ttm)N/D
EPS (ttm)-0,1520
Prossima data utili15 nov 2021
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    CV Sciences, Inc. Appoints Haskell & White LLP as Auditor

    SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it has appointed Haskell & White LLP ("H&W") as the Company's new independent registered public accounting firm. "Following a thorough selection process, the Company's Audit Committee has concluded that H&W is best positioned to meet the evolving needs of CV Sciences. This i

  • GlobeNewswire

    CV Sciences, Inc. Announces Convertible Note Financing

    SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it has entered into a securities purchase agreement with an institutional investor, providing for the sale and issuance of convertible notes due 2022 in the aggregate original principal amount of $1.06 million. Upon our filing with the Securities and Exchange Commission of a

  • GlobeNewswire

    CV Sciences, Inc. Reports Third Quarter 2021 Financial Results

    SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the quarter ended September 30, 2021. Third Quarter 2021 and Recent Financial and Operating Highlights Revenue of $5.1 million for third quarter of 2021, compared to $5.6 million for the third quarter of 2020;Gross margin of 46.2% for third quarter of 20